amiodarone

Amiodarone is an antiarrhythmic compound that inhibits ATP-sensitive potassium channels (IC₅₀ = 19.1 μM) and can induce pulmonary toxicity. It has shown some antiviral activity in diseases caused by SARS-CoV-2 and is commonly used to establish animal models of pulmonary fibrosis.

Amiodarone hydrochloride is an anti-anginal agent and a class III antiarrhythmic drug that inhibits potassium channels (including wild-type hERG channels and their tail currents, with an IC₅₀ of approximately 45 nM) as well as voltage-gated sodium channels. This leads to prolonged action potential duration in ventricular and atrial myocytes, resulting in reduced heart rate and vascular resistance. It activates ERK1/2 and p38 MAPK signaling pathways in fibroblasts, promoting cell proliferation and myofibroblast differentiation. Amiodarone hydrochloride is widely used in the study of supraventricular and ventricular arrhythmias and can also be used to establish pulmonary fibrosis animal models.

L-6355 is an agent of bioactive chemicals.

L-6424 is an intermediate of Amiodarone and a non-selective ion channel blocker. It has an antiarrhythmic.

Deiodoamiodarone is an intermediate of amiodarone. Amiodarone is an α/β-adrenergic receptor antagonist and coronary vasodilator.

Di-N-desethyl Amiodarone hydrochloride, a metabolite of Amiodarone, functions as a potent inhibitor of the respiratory chain [1].

Amiodarone-d4 HCl is a deuterated compound of Amiodarone HCl. Amiodarone HCl has a CAS number of 19774-82-4. Amiodarone hydrochloride is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.

Amiodarone-d10 Hydrochloride is a deuterated compound of Amiodarone Hydrochloride. Amiodarone Hydrochloride has a CAS number of 19774-82-4. Amiodarone hydrochloride is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.

Amiodarone hydrochloride (Standard) is a reference standard for research and analysis in studies involving Amiodarone hydrochloride. Amiodarone hydrochloride is an anti-anginal agent and a class III antiarrhythmic drug that inhibits potassium channels (including wild-type hERG channels and their tail currents, with an IC₅₀ of approximately 45 nM) as well as voltage-gated sodium channels. This leads to prolonged action potential duration in ventricular and atrial myocytes, resulting in reduced heart rate and vascular resistance. It activates ERK1/2 and p38 MAPK signaling pathways in fibroblasts, promoting cell proliferation and myofibroblast differentiation. Amiodarone hydrochloride is widely used in the study of supraventricular and ventricular arrhythmias and can also be used to establish pulmonary fibrosis animal models.

CTP-amiodarone, a cellular-penetrating conjugate of myocardial cell-targeting peptide and Amiodarone, exhibits anti-arrhythmic activity by blocking Na+, K+, and Ca2+ channels as well as β-adrenergic receptors.

Desethylamiodarone hydrochloride (N-desethylamiodarone hydrochloride), formed by the CYP3A isozyme, is the main active metabolite of amiodarone, an antiarrhythmic drug that inhibits ATP-sensitive potassium channels with an IC50 of 19.1 μM.

Diethylamiodarone is the main metabolite of amiodarone in vivo.

Desethylamiodarone hydrochloride (Standard) is a reference standard for research and analysis in studies involving Desethylamiodarone hydrochloride. Desethylamiodarone hydrochloride (N-desethylamiodarone hydrochloride), formed by the CYP3A isozyme, is the main active metabolite of amiodarone, an antiarrhythmic drug that inhibits ATP-sensitive potassium channels with an IC50 of 19.1 μM.

Dronedarone hydrochloride (SR33589) is an amiodarone analog which has an effective and promising treatment for Atrial fibrillation.

Butoprozine exhibits various cardiac electrophysiological effects: it prolongs action potential duration, akin to the effect of amiodarone; it inhibits the plateau phase, similar to verapamil; and it reduces both amplitude and the maximum rate of depolarization.

Benziodarone is a purine analog and selective inhibitor of transthyretin amyloidogenesis, applicable for studying gout and hyperuricaemia.

Budiodarone(ATI-2042)is a chemical analog of an antiarrhythmic drug and amiodarone. Budedalone is promising as an antiarrhythmic agent for the prevention of atrial fibrillation.

GYKI-16638 is a novel antiarrhythmic agent that demonstrates combined class IB and class III antiarrhythmic properties in human ventricular muscles, similar to the electrophysiological findings after chronic amiodarone treatment. In addition, GYKI 16638 h

N-Desbutyl dronedarone is an active metabolite of the antiarrhythmic agent dronedarone .1,2,3It is formed from dronedarone by cytochrome P450s (CYPs) and monoamine oxidase (MAO) in human hepatocyte preparations.4N-Desbutyl dronedarone inhibits the binding of 3,3',5-triiodo-L-thyronine to the thyroid hormone receptors TRα1and TRβ1(IC50s = 59 and 280 μM for the chicken and human receptors, respectively).1It inhibits CYP2J2-mediated formation of 14,15-EET from arachidonic acid and soluble epoxide hydrolase-mediated formation of 14,15-DHET from 14,15-EET (IC50s = 1.59 and 2.73 μM, respectively, in cell-free assays).2N-Desbutyl dronedarone decreases intracellular ATP levels in H9c2 rat cardiomyocytes (IC50= 1.07 μM) and inhibits mitochondrial complex I, also known as NADH dehydrogenase, and mitochondrial complex II, also known as succinate dehydrogenase, activities in isolated rat heart mitochondria (IC50s = 11.94 and 24.54 μM, respectively).3 1.Van Beeren, H.C., Jong, W.M.C., Kaptein, E., et al.Dronerarone acts as a selective inhibitor of 3,5,3'-triiodothyronine binding to thyroid hormone receptor-α1: in vitro and in vivo evidenceEndocrinology144(2)552-558(2003) 2.Karkhanis, A., Tram, N.D.T., and Chan, E.C.Y.Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acidsBiochem. Pharmacol.146188-198(2017) 3.Karkhanis, A., Leow, J.W.H., Hagen, T., et al.Dronedarone-induced cardiac mitochondrial dysfunction and its mitigation by epoxyeicosatrienoic acidsToxicol. Sci.163(1)79-91(2018) 4.Klieber, S., Arabeyre-Fabre, C., Moliner, P., et al.Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drugPharmacol. Res. Perspec.2(3)e00044(2014)

Dronedarone (SR 33589) is an amiodarone analogue which has an effective and promising treatment for Atrial fibrillation.

Budiodarone tartrate (ATI-2042 tartrate) is a chemical analog of Amiodarone, an antiarrhythmic drug that inhibits sodium, potassium, and calcium ion channels. It is used for studying atrial fibrillation.

Dronedarone-d6 HCl is a deuterated compound of Dronedarone HCl. Dronedarone HCl has a CAS number of 141625-93-6. Dronedarone hydrochloride is an amiodarone analog which has an effective and promising treatment for Atrial fibrillation.